COVID-19 and Alzheimer’s Disease: A Literature Review
Louis Hardan, Dimitar Filtchev, Ratiba Kassem, Rim Bourgi, Monika Łukomska−Szymańska, Hassan Tarhini, Fouad Salloum-Yared, Davide Mancino, Naji Kharouf, Youssef Haïkel
Abstract
There are a number of potential implications for the field of Alzheimer's disease (AD) stemming from the global spread of "SARS-COV-2". Many studies that were conducted by Cleveland Clinic researchers identified a link between COVID-19 infection and brain abnormalities seen in people with AD. This article explains the association between COVID-19 and AD and how people with AD are affected by COVID-19, whether directly or indirectly. First, this article begins by explaining AD and its types, then giving an overview about COVID-19, its symptoms and the associated complications. Then, direct and indirect consequences of COVID-19 on people experiencing AD are discussed briefly. Some management strategies are recommended at the end of this article in addition to a future perspective on this topic. This article concludes by summarizing the main points mentioned about the association between COVID-19 and AD.